Cancer Biopsy Market Size, Share & Trends Analysis Report By Product (Instruments, Kits & Consumables, Services), By Type (Tissue Biopsies, Liquid Biopsies), By Application, By Region, And Segment Forecasts, 2020 - 2027

Published: Dec, 2020 | Pages: 140 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

"Cancer Biopsy Market Growth & Trends

The global cancer biopsy market size is expected to reach USD 32.63 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.33% from 2020 to 2027. Several methods of diagnosing cancer patients exist currently, however, biopsy remains to be the only definitive method to confirm the onset of the disease in a patient. Since it involves close examination of organs/tissues, doctors largely rely on biopsies to perform accurate and early diagnosis in susceptible patients.

There has been a significant transition from tumor to liquid biopsy, which is expected to increase the adoption of kits as well as consumables. Acknowledging this trend, various market players have invested in the development of novel kits in order to expand their biopsy kits portfolio. For instance, Biocept, Inc. recently launched a liquid biopsy kit that is designed for research use pertaining to gene mutations.

Additionally, tumor biopsy is most adopted for the diagnosis on individual levels, along with monitoring the effects of ongoing oncology treatment. Shortcomings of liquid biopsies such as lack of robust efficacy evaluations and their associated high costs are currently bridged by tissue biopsies. This has made tissue biopsy a gold-standard procedure in the present diagnostic scenario.

Moreover, revolutionary advancements in liquid biopsies are expected to be a key factor fueling the overall market growth. Liquid biopsies are expected to offer lucrative opportunities in the field of genomic data analysis and oncology-based personalized medicine. Key players operating in the market such as Cardinal Health; BD; and Biocept, Inc. are focusing on the development of novel or automated biopsies to sustain the current market competition.

The liquid biopsies segment is expected to expand at an exponential rate in the coming years, wherein, increasing investments and strategic initiatives by companies involved in biopharmaceutical manufacturing and genomic data analysis are expected to play a central role. For instance, in early 2018, Seven Bridges Genomics, a company engaged in biomedical data analysis, announced its plan to enter the liquid biopsy market space.

Such emerging companies are inclined towards collaborating with well-established industry participants, including SOPHiA Genetics, QIAGEN Bioinformatics, Agilent Technologies, and Fabric Genomics. This trend is further expected to favor overall market growth.

In April 2020, Personal Genome Diagnostics, a liquid biopsy company, announced that its proprietary comprehensive genomic profiling diagnostic kit designed for oncology diagnostics received FDA approval. This kit is designed to enhance the scalability of precision medicine. With the launch of AdnaTest Lung Cancer Kit and AdnaTest Prostate Cancer Panel AR-V7 Kit, the company has further strengthened its position in the market, by affiliating with the American Association for Cancer Research (AACR).

Cancer Biopsy Market Report Highlights

• By product, kits and consumables accounted for the largest revenue share in 2019 and are anticipated to maintain their lead throughout the forecast period. A significant transition from tumor to liquid biopsy is expected to increase the adoption of kits as well as consumables

• Based on type, tissue biopsies led the market in 2019. They are still considered to be a mainstay of biopsies and are largely adopted across various diagnosis applications

• In terms of application, breast cancer dominated the market in 2019 and is expected to maintain its lead from 2020 to 2027. Open surgical biopsy is considered to be a reference standard for the evaluation of patients with a suspicious breast lesion, which is attributed to its proven accuracy in diagnosing breast lesions, further contributing to the revenue generated by this segment

• North America held the largest revenue share of over 37.0% in 2019 owing to a concentrated pool of active organizations as well as cancer foundations. A Strong network of government organizations and private cancer foundations in the U.S. has made a significant contribution to the regional revenue generation

• Key players are focusing on developing novel biopsy platforms, set to achieve business expansion, further contributing to the revenue generation of the market"

 "Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Research Methodology
                 1.2 Research Assumptions
                     1.2.1 Estimates and Forecast Timeline
                 1.3 Research Methodology
                 1.4 Information Procurement
                     1.4.1 Purchased Database
                     1.4.2 GVR’s Internal Database
                     1.4.3 Secondary Sources
                     1.4.4 Primary Research
                     1.4.5 Details of Primary Research
                 1.5 Information or Data Analysis
                     1.5.1 Data Analysis Models
                         1.5.1.1 End-use landscape assessment
                         1.5.1.2 market origin assessment
                         1.5.1.3 Oncology diagnosis: Market competition analysis
                 1.6 Market Formulation & Validation
                 1.7 Model Details
                     1.7.1 Commodity Flow Analysis
                         1.7.1.1 Approach 1: Commodity Flow Approach
                         1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
                 1.8 Global Market: CAGR Calculation
                 1.9 List of Secondary Sources
                 1.10 List of Primary Sources
                 1.11 Objectives
                     1.11.1 Objective 1:
                     1.11.2 Objective 2:
Chapter 2 Market Definitions
Chapter 3 Executive Summary
                 3.1 Market Summary, 2019 (USD Billion)
Chapter 4 Market Variables, Trends & Scope
                 4.1 Market Segmentation
                 4.2 Cancer Biopsy Market Lineage Outlook
                     4.2.1 Parent market outlook
                         4.2.1.1 Top 10 Liquid Biopsy Innovators
                 4.3 Penetration and Growth Prospect Mapping
Chapter 5 Industry Outlook
                 5.1 Market Driver Analysis
                     5.1.1 Advent of liquid biopsy
                     5.1.2 Transition of novel oncology diagnostics from bench to clinics
                     5.1.3 Advances in quality and payment pertaining to genetic cancer tests
                 5.2 Market Restraint Analysis
                     5.2.1 Risks associated with biopsy procedures
Chapter 6 Business Environment Analysis
                 6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
                     6.1.1 Political landscape
                         6.1.1.1 Strengths
                         6.1.1.2 Weaknesses
                         6.1.1.3 Opportunities
                         6.1.1.4 Threats
                     6.1.2 Economic landscape
                         6.1.2.1 Strengths
                         6.1.2.2 Weaknesses
                         6.1.2.3 Opportunities
                         6.1.2.4 Threats
                     6.1.3 Social landscape
                         6.1.3.1 Strengths
                         6.1.3.2 Weaknesses
                         6.1.3.3 Opportunities
                         6.1.3.4 Threats
                     6.1.4 Technology landscape
                         6.1.4.1 Strengths
                         6.1.4.2 Weaknesses
                         6.1.4.3 Opportunities
                         6.1.4.4 Threats
                 6.2 Porter’s Five Forces Analysis
                 6.3 Market entry strategies
Chapter 7 Competitive Analysis
                 7.1 Market Impact Analysis by Key Participants
                     7.1.1 Ansoff matrix
                     7.1.2 Company/Competition Categorization (Primary & Secondary market participants)
Chapter 8 Product Business Analysis
                 8.1 Cancer Biopsy Market: Product Movement Analysis
                 8.2 Instruments
                     8.2.1 Cancer Biopsy instruments market estimates and forecasts, 2016 -2027 (USD Billion)
                 8.3 Kits and Consumables
                     8.3.1 Cancer Biopsy kits and consumables market estimates and forecast, 2016 - 2027 (USD Billion)
                 8.4 Services
                     8.4.1 Cancer Biopsy services market estimates and forecast, 2016 - 2027 (USD Billion)
Chapter 9 Type Business Analysis
                 9.1 Cancer Biopsy Market: Type Movement Analysis
                 9.2 Cancer Biopsy Market: Comparative Analysis of Biopsy Type
                 9.3 Tissue Biopsies
                     9.3.1 Cancer Tissue Biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
                     9.3.2 Needle Biopsies
                         9.3.2.1 Cancer Needle Biopsies market estimates and forecasts, 2016 - 2027 (USD Billion)
                         9.3.2.2 Fine Needle Aspiration (FNA)
                             9.3.2.2.1 FINE NEEDLE ASPIRATION (FNA) market estimates and forecasts, 2016 - 2027 (USD billion)
                         9.3.2.3 Core Needle Biopsy (CNB)
                             9.3.2.3.1 Core Needle Biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
                     9.3.3 Cancer Surgical Biopsy
                         9.3.3.1 Surgical Biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
                 9.4 Liquid Biopsies
                     9.4.1 Liquid Biopsies market estimates and forecasts, 2016 - 2027 (USD Billion)
                 9.5 Others
                     9.5.1 Other Biopsies market estimates and forecasts, 2016 - 2027 (USD Billion)
Chapter 10 Application Business Analysis
                 10.1 Cancer Biopsy Market: Application Movement Analysis
                 10.2 Breast Cancer
                     10.2.1 Breast Cancer Biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
                 10.3 Colorectal Cancer
                     10.3.1 Colorectal Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.4 Cervical Cancers
                     10.4.1 Cervical Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.5 Lung Cancers
                     10.5.1 Lung Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.6 Prostate Cancers
                     10.6.1 Prostate Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.7 Skin Cancers
                     10.7.1 Skin Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.8 Blood Cancers
                     10.8.1 Blood Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.9 Kidney Cancers
                     10.9.1 Kidney Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.10 Liver Cancers
                     10.10.1 Liver Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.11 Pancreatic Cancers
                     10.11.1 Pancreatic Cancer BiopsY market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.12 Ovarian Cancers
                     10.12.1 Ovarian Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                 10.13 Others
                     10.13.1 Other Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Chapter 11 Regional Business Analysis
                 11.1 Cancer Biopsy Market: Regional Movement Analysis
                 11.2 North America
                     11.2.1 North America Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                     11.2.2 U.S.
                         11.2.2.1 U.S. Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.2.2.2 U.S. Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.2.2.3 U.S. Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                 11.3 Canada
                         11.3.1.1 Canada Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.3.1.2 Canada Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.3.1.3 Canada Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                 11.4 Europe
                     11.4.1 Europe Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                         11.4.2 Germany
                         11.4.2.1 Germany Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.4.2.2 Germany Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.4.2.3 Germany Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                         11.4.3 U.K.
                         11.4.3.1 U.K. Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.4.3.2 U.K. Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.4.3.3 U.K. Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.4.4 France
                         11.4.4.1 France Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.4.4.2 France Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.4.4.3 France Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.4.5 Spain
                         11.4.5.1 Spain Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.4.5.2 Spain Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.4.5.3 Spain Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.4.6 Italy
                         11.4.6.1 Italy Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.4.6.2 Italy Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.4.6.3 Italy Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                 11.5 Asia Pacific
                     11.5.1 Asia Pacific Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                     11.5.2 Japan
                         11.5.2.1 Japan Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.5.2.2 Japan Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.5.2.3 Japan Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.5.3 China
                         11.5.3.1 China Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.5.3.2 China Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.5.3.3 China Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.5.4 India
                         11.5.4.1 India Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.5.4.2 India Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.5.4.3 India Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.5.5 Thailand
                         11.5.5.1 Thailand Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.5.5.2 Thailand Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.5.5.3 Thailand Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.5.6 South Korea
                         11.5.6.1 South Korea Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.5.6.2 South Korea Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.5.6.3 South Korea Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                 11.6 Latin America
                     11.6.1 Latin America Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                     11.6.2 Brazil
                         11.6.2.1 Brazil Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.6.2.2 Brazil Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.6.2.3 Brazil Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.6.3 Mexico
                         11.6.3.1 Mexico Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.6.3.2 Mexico Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.6.3.3 Mexico Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.6.4 Argentina
                         11.6.4.1 Argentina Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.6.4.2 Argentina Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.6.4.3 Argentina Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                 11.7 Middle East and Africa
                     11.7.1 MEA Cancer Biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
                     11.7.2 South Africa
                         11.7.2.1 South Africa Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.7.2.2 South Africa Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.7.2.3 South Africa Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
                     11.7.3 Saudi Arabia
                         11.7.3.1 Saudi Arabia Cancer Biopsy market estimates and forecast, by product, 2016 - 2027 (USD Billion)
                         11.7.3.2 Saudi Arabia Cancer Biopsy market estimates and forecast, by type, 2016 - 2027 (USD Billion)
                         11.7.3.3 Saudi Arabia Cancer Biopsy market estimates and forecast, by application, 2016 - 2027 (USD Billion)
Chapter 12 Company Profiles
                 12.1 Company Profiles
                     12.1.1 QIAGEN
                         12.1.1.1 Company overview
                         12.1.1.2 Financial Performance
                         12.1.1.3 Product benchmarking
                         12.1.1.4 Strategic Initiatives
                     12.1.2 Illumina, Inc.
                         12.1.2.1 Company overview
                         12.1.2.2 Product benchmarking
                         12.1.2.3 Financial Performance
                         12.1.2.4 Strategic Initiatives
                     12.1.3 ANGLE plc
                         12.1.3.1 Company overview
                         12.1.3.2 Financial Performance
                         12.1.3.3 Product benchmarking
                         12.1.3.4 Strategic initiatives
                     12.1.4 BD (Becton, Dickinson and Company)
                         12.1.4.1 Company overview
                         12.1.4.2 Financial performance
                         12.1.4.3 Product benchmarking
                         12.1.4.4 Strategic initiatives
                     12.1.5 Myriad Genetics
                         12.1.5.1 Company overview
                         12.1.5.2 Counsyl, Inc.
                         12.1.5.2.1 Company overview
                         12.1.5.3 Financial performance
                         12.1.5.4 Product benchmarking
                         12.1.5.5 Strategic initiatives
                     12.1.6 Hologic, Inc.
                         12.1.6.1 Company overview
                         12.1.6.2 Financial performance
                         12.1.6.3 Product benchmarking
                     12.1.7 BIOCEPT, INC.
                         12.1.7.1 Company overview
                         12.1.7.2 Financial performance
                         12.1.7.3 Product benchmarking
                         12.1.7.4 Strategic initiatives
                     12.1.8 Thermo Fisher Scientific, Inc.
                         12.1.8.1 Company overview
                         12.1.8.2 Financial performance
                         12.1.8.3 Product benchmarking
                     12.1.9 Danaher
                         12.1.9.1 Company overview
                         12.1.9.2 Beckman Coulter, Inc.
                         12.1.9.3 Radiometer Medical ApS
                         12.1.9.4 HemoCue AB
                         12.1.9.5 Financial performance
                         12.1.9.6 Product benchmarking
                     12.1.10 F. Hoffmann-La Roche Ltd.
                         12.1.10.1 Company overview
                         12.1.10.2 FOUNDATION MEDICINE, INC.
                         12.1.10.3 Financial performance
                         12.1.10.4 Product benchmarking
                     12.1.11 Lucence Diagnostics Pte. Ltd.
                         12.1.11.1 Company overview
                         12.1.11.2 Financial performance
                         12.1.11.3 Product benchmarking
                         12.1.11.4 Strategic initiatives
                     12.1.12 GRAIL, Inc.
                         12.1.12.1 Company overview
                         12.1.12.2 Financial performance
                         12.1.12.3 Product benchmarking
                         12.1.12.4 Strategic initiatives
                     12.1.13 Guardant Health
                         12.1.13.1 Company overview
                         12.1.13.2 Financial performance
                         12.1.13.3 Product benchmarking
                         12.1.13.4 Strategic initiatives
                     12.1.14 Exact Sciences Corporation
                         12.1.14.1 Company overview
                         12.1.14.2 Financial performance
                         12.1.14.3 Product benchmarking
                         12.1.14.4 Strategic initiatives
                     12.1.15 Freenome Holdings, Inc.
                         12.1.15.1 Company overview
                         12.1.15.2 Financial performance
                         12.1.15.3 Product benchmarking
                         12.1.15.4 Strategic initiatives
                     12.1.16 Biodesix (Integrated Diagnostics)
                         12.1.16.1 Company overview
                         12.1.16.2 Financial performance
                         12.1.16.3 Product benchmarking
                         12.1.16.4 Strategic initiatives
                     12.1.17 Oncimmune
                         12.1.17.1 Company overview
                         12.1.17.2 Financial performance
                         12.1.17.3 Product benchmarking
                         12.1.17.4 Strategic initiatives
                     12.1.18 Epigenomics AG
                         12.1.18.1 Company overview
                         12.1.18.2 Financial performance
                         12.1.18.3 Product benchmarking
                         12.1.18.4 Strategic initiatives
                     12.1.19 HelioHealth (Laboratory for Advanced Medicine)
                         12.1.19.1 Company overview
                         12.1.19.2 Financial performance
                         12.1.19.3 Product benchmarking
                         12.1.19.4 Strategic initiatives
                     12.1.20 Genesystems, Inc. (Genesys Biolabs)
                         12.1.20.1 Company overview
                         12.1.20.2 Financial performance
                         12.1.20.3 Product benchmarking
                         12.1.20.4 Strategic initiatives
                     12.1.21 Chronix Biomedical, Inc.
                         12.1.21.1 Company overview
                         12.1.21.2 Financial performance
                         12.1.21.3 Product benchmarking
                         12.1.21.4 Strategic initiatives
                     12.1.22 Personal Genome Diagnostics Inc.
                         12.1.22.1 Company overview
                         12.1.22.2 Financial performance
                         12.1.22.3 Product benchmarking
                         12.1.22.4 Strategic initiatives
                     12.1.23 Natera, Inc.
                         12.1.23.1 Company overview
                         12.1.23.2 Financial performance
                         12.1.23.3 Product benchmarking
                         12.1.23.4 Strategic initiatives
                     12.1.24 Personalis Inc.
                         12.1.24.1 Company overview
                         12.1.24.2 Financial performance
                         12.1.24.3 Product benchmarking
                         12.1.24.4 Strategic initiatives"

"List of Tables

Table 1 List of secondary sources
Table 2 Surgical biopsy: Feasibility analysis across cancer diagnosis
Table 3 Comparative analysis of traditional and liquid liver biopsies
Table 4 North America cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 5 North America cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 6 North America cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 7 U.S. cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 8 U.S. cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 9 U.S. cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 10 Canada cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 11 Canada cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 12 Canada cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 13 Europe cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 14 Europe cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 15 Europe cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 16 Germany cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 17 Germany cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 18 Germany cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 19 U.K. cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 20 U.K. cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 21 U.K. cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 22 France cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 23 France cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 24 France cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 25 Spain cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 26 Spain cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 27 Spain cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 28 Italy cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 29 Italy cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 30 Italy cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 31 Asia Pacific cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 32 Asia Pacific cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 33 Asia Pacific cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 34 Japan cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 35 Japan cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 36 Japan cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 37 China cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 38 China cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 39 China cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 40 India cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 41 India cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 42 India cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 43 Thailand cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 44 Thailand cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 45 Thailand cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 46 South Korea cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 47 South Korea cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 48 South Korea cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 49 Latin America cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 50 Latin America cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 51 Latin America cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 52 Brazil cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 53 Brazil cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 54 Brazil cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 55 Mexico cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 56 Mexico cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 57 Mexico cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 58 Argentina cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 59 Argentina cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 60 Argentina cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 61 MEA cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 62 MEA cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 63 MEA cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 64 South Africa cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 65 South Africa cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 66 South Africa cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
Table 67 Saudi Arabia cancer biopsy market estimates and forecasts, by product, 2016 - 2027 (USD Billion)
Table 68 Saudi Arabia cancer biopsy market estimates and forecasts, by type, 2016 - 2027 (USD Billion)
Table 69 Saudi Arabia cancer biopsy market estimates and forecasts, by application, 2016 - 2027 (USD Billion)
"	"List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 End-use landscape: Cancer biopsy product penetration
Fig. 8 Cancer biopsy: Market origin/ parent market assessment
Fig. 9 Market competition analysis: Early diagnosis industry sector
Fig. 10 Market formulation & validation
Fig. 11 Cancer biopsy market snapshot
Fig. 12 Cancer biopsy market segmentation
Fig. 13 Biopsy workflow
Fig. 14 Biopsy types
Fig. 15 Top 10 companies in the liquid biopsy business
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Cancer Biopsy market driver impact
Fig. 18 External factors driving the demand for cancer biopsy
Fig. 19 Cancer Biopsy market restraint impact
Fig. 20 Porter’s Five Forces Analysis
Fig. 21 Factors impacting market entry strategies
Fig. 22 Ansoff Matrix
Fig. 23 Competition Categorization
Fig. 24 Cancer biopsy market: Products outlook and key takeaways
Fig. 25 Cancer biopsy market: Product movement analysis
Fig. 26 Cancer biopsy instruments market estimates and forecasts, 2016 - 2027 (USD BILLION)
Fig. 27 Cancer Biopsy Kits: Cardinal Health
Fig. 28 Cancer biopsy kits and consumables market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 29 Cancer biopsy services market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 30 Cancer biopsy market: Type outlook and key takeaways
Fig. 31 Cancer biopsy market: Type movement analysis
Fig. 32 Tissue Biopsy Vs Liquid Biopsy: Comparative Analysis
Fig. 33 Cancer tissue biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 34 Cancer needle biopsies market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 35 Estimated increment in thyroid cancer cases/thyroid cancer FNAB diagnosis in Korea:2005-2013
Fig. 36 Fine needle aspiration (FNA) market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 37 Core needle biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 38 Surgical biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 39 Liquid biopsies market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 40 Other biopsies market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 41 Cancer biopsy market: Application outlook and key takeaways
Fig. 42 Cancer Biopsy market: Application Movement Analysis
Fig. 43 New female breast in situ cancer cases by age estimated in the U.S.: 2017
Fig. 44 New female breast invasive cancer cases by age estimated in the U.S.: 2017
Fig. 45 New female breast cancer deaths by age estimated in the U.S.: 2017
Fig. 46 Breast cancer biopsy market estimates and forecasts, 2016 - 2027 (USD Billion)
Fig. 47 Colorectal cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 48 Cervical cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 49 Lung cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 50 Prostate cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 51 Skin cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 52 Blood cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 53 Kidney cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 54 Liver cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 55 Pancreatic cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 56 Ovarian cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 57 Other cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 58 Cancer biopsy market: Regional outlook and key takeaways
Fig. 59 Cancer biopsy market: Regional movement analysis
Fig. 60 North America cancer biopsy market overview
Fig. 61 North America cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 62 U.S. cancer biopsy market overview
Fig. 63 U.S. cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 64 Canada cancer biopsy market overview
Fig. 65 Canada cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 66 Europe cancer biopsy market overview
Fig. 67 Europe cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 68 Germany cancer biopsy market overview
Fig. 69 Germany cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 70 U.K. cancer biopsy market overview
Fig. 71 U.K. cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 72 France cancer biopsy market overview
Fig. 73 France cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 74 Spain cancer biopsy market overview
Fig. 75 Spain cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 76 Italy cancer biopsy market overview
Fig. 77 Italy cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 78 Asia Pacific cancer biopsy market overview
Fig. 79 Asia Pacific cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 80 Japan cancer biopsy market overview
Fig. 81 Japan cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 82 China cancer biopsy market overview
Fig. 83 China cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 84 India cancer biopsy market overview
Fig. 85 India cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 86 Thailand cancer biopsy market overview
Fig. 87 Thailand cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 88 South Korea cancer biopsy market overview
Fig. 89 South Korea cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 90 Latin America cancer biopsy market overview
Fig. 91 Latin America cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 92 Brazil cancer biopsy market overview
Fig. 93 Brazil cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 94 Mexico cancer biopsy market overview
Fig. 95 Mexico cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 96 Argentina cancer biopsy market overview
Fig. 97 Argentina cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 98 Middle East & Africa cancer biopsy market overview
Fig. 99 MEA cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 100 South Africa cancer biopsy market overview
Fig. 101 South Africa cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)
Fig. 102 Saudi Arabia cancer biopsy market overview
Fig. 103 Saudi Arabia cancer biopsy market estimates and forecast, 2016 - 2027 (USD Billion)"